{
    "2018-12-25": [
        [
            {
                "time": "",
                "orginal_text": "医药生物行业周报:三季报披露期,坚守业绩主线",
                "features": {
                    "keywords": [
                        "医药生物",
                        "三季报",
                        "业绩",
                        "披露"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "泰格医药三季报跟踪:Q3增速放缓,无碍长期发展前景",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "三季报",
                        "Q3",
                        "增速",
                        "长期发展"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "医药生物行业周报:行业估值位于历史底部,可逐步配置优质个股",
                "features": {
                    "keywords": [
                        "医药生物",
                        "估值",
                        "历史底部",
                        "优质个股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "大额回购+业绩预喜，这些超跌股已获北上资金“举牌” 盈利能力下降",
                "features": {
                    "keywords": [
                        "大额回购",
                        "业绩预喜",
                        "超跌股",
                        "北上资金",
                        "盈利能力下降"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "A股2018年震荡走低，三板块逆势逞强走出独立行情",
                "features": {
                    "keywords": [
                        "A股",
                        "2018年",
                        "震荡走低",
                        "三板块",
                        "独立行情"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}